Molecular diagnostics is technically defined as a class of diagnostic test that analyzes proteins or nucleic acids at a higher molecular level. The nucleic acids and proteins that belong to individual patients or foreign organisms help in identifying a specific therapy, health condition, or risk of developing a specific disease. In medical terms, molecular diagnostics is better known as (MDx) evaluating the new class of diagnostic tests to test the status and health condition of a specific disease. Today, MDx is included amongst the fastest growing market segment within the in-vitro diagnostic (IVD) sector. It is mainly driven by high sensitivity, accuracy, quick turnaround time, cost-effective testing, and easy workflow.

1. Title:
Introduction :
Albany, NY, April 04 , 2014
PressRelease :
Transparency Market Research has announced the addition of a new market report based on
Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth,
Trends and Forecast to 2019 in addition to their comprehensive database. This industry
is considered as the most well-established and attractive market for clinical applications. It
is valued at USD 8.7 billion by 2019 and expected to grow at a CAGR of 11.1% from 2013
to 2019.
Molecular diagnostics is the class of diagnostic test that explores and evaluates nucleic acids
or proteins at a molecular level. Our generation is furnished with some of the most realistic
and innovative ideas in biotechnology which is witnessed in the form of molecular
diagnostics.
Since 1990 the market for molecular diagnostics has expanded and evolved profusely. With
the introduction of PCR test for HIV and Chlamydia Trachomatis/Neisseria Gonorrhoeae
(CT/NG), this industry comes across as tough and a science-oriented regulator. In the
primitive times, the usage of molecular diagnostics was restricted due to high cost of tests
and requirement of skilled professionals. Nonetheless, this was overcome by the reduction
in labor cost, cost per sample analysis, introduction and development in the advanced
technologies and automation systems.
In its new market research report titled “Molecular Diagnostics Market (PCR,
Next Generation Sequencing, Microarray, Infectious diseases, Genetic
disease, Oncology testing, Blood donor screening) - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,”
Transparency Market Research Predicts this market to post a CAGR of
11.1% through 2019

2. Currently, molecular diagnostics constitutes a trivial section of the overall diagnostics
market, but is reckoned as the fastest growing sector across the globe. By far it is
approached as the fastest growing sector of the in-vitro diagnostics market. This is clearly
supported by the fact as now-a-days, the molecular diagnostics tests are widely performed
for testing infectious diseases such as HIV, HPV, HCV, HAI, cancer testing, genetic diseases,
HLA testing, and many others. There are molecular diagnostic kits available for
pharmacogenetics and blood donor screening testing processes too.
The first-generation amplification, fluorescent in situ hybridization (FISH), DNA probes, and
second-generation biochips and micro fluidics are the technologies that comprise molecular
diagnostics.
Moreover, the next-generation signal detection, molecular labels, and biosensors are
handful of other influencing factors that showcases the discovery of therapeutic molecules,
optimization of drug therapy, and the screening and diagnosis of patients. The next-
generation sequencing is developing rapidly owing to its prompt turnaround time, low cost,
reduction in cost of sequencing, high sensitivity, and convenient workflow.
Molecular diagnostics is considered as a highly evolving market due to the rise in chronic
infections, increasing investments in R&D, growing geriatric population, increasing demand
for personalized medicines, and R&D activities for biomarker identification equipped with
emergence of new technology and applications of various tests. Molecular diagnostics test is
placed in the fast lane development so that infectious diseases testing, oncology testing,
genetic testing, blood screening, cardiovascular testing and other medical procedures are
carried out promptly.
According to the current market statistics, molecular diagnostic’s major revenue is
dominated by infectious diseases that standalone captures 60% of the overall molecular
diagnostic applications market share. However, the remaining one third is attributed to the
blood donor screening and genetic testing procedures. The growth of this sector is also seen
through the rising incidences of hospital acquired infections (HAI) that is anticipated as the
fastest acquiring segment within infectious diseases. It is further expected to grow at a
CAGR rate of 15.1% in the forecast period of 2013-2019. Similarly, the growing incidence of
cervical cancer caused due to Human Papilloma Virus (HPV) is a noteworthy contributor to
the expansion of this segment. HPV testing is augmented to rise at a CAGR of 14.8% during
the same forecast period of 2013-2019. In addition, the HLA typing testing and oncology
testing are also projected to grow at a rapid rate during the same forecast period.
Considering the geographical status of the molecular diagnostics market, North America and
Europe capture the majority of the market share due to their investments in genomics and
proteomics, and rising awareness and usage of personalized medicines. The geographical
share of North America and Europe for 2012 (%) in terms of molecular diagnostics market
is 42.68% and 29.79%. Nevertheless, rising patient awareness towards wellness, usage of

3. preventive medicines, access to technological advanced medical equipment and products,
and wide scale economic developments are subsequently taking places across other
countries in Asia-Pacific (17.47%) and RoW (Rest of the World) (10.06%) respectively.
About Us
Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze
information.
Our data repository is continuously updated and revised by a team of research experts, so
that it always reflects the latest trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary and secondary research
techniques in developing distinctive data sets and research material for business reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://de.transparencymarketresearch.com/
Visit: http://www.europlat.org/
Visit: http://semiconductor-market-reports.blogspot.com
Visit: http://www.transparencymarketresearch.com/